> top > docs > PMC:7717205 > spans > 159-1815 > annotations

PMC:7717205 / 159-1815 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
16 21-68 Species denotes Severe acute respiratory syndrome coronavirus 2 Tax:2697049
17 72-89 Species denotes novel coronavirus Tax:2697049
18 335-343 Species denotes patients Tax:9606
19 170-179 Disease denotes mortality MESH:D003643
20 262-286 Disease denotes coronavirus disease 2019 MESH:C000657245
21 288-296 Disease denotes COVID-19 MESH:C000657245
22 349-357 Disease denotes COVID-19 MESH:C000657245
23 420-441 Disease denotes pleural complications MESH:D010995
29 587-595 Species denotes patients Tax:9606
30 681-689 Species denotes Patients Tax:9606
31 700-707 Species denotes patient Tax:9606
32 622-630 Disease denotes COVID-19 MESH:C000657245
33 728-749 Disease denotes pleural complications MESH:D010995
39 833-841 Species denotes patients Tax:9606
40 915-962 Species denotes severe acute respiratory syndrome coronavirus 2 Tax:2697049
41 1006-1014 Species denotes patients Tax:9606
42 1107-1115 Species denotes patients Tax:9606
43 871-879 Disease denotes COVID-19 MESH:C000657245
50 1246-1254 Species denotes patients Tax:9606
51 1409-1417 Species denotes patients Tax:9606
52 1508-1516 Species denotes patients Tax:9606
53 1260-1268 Disease denotes COVID-19 MESH:C000657245
54 1343-1364 Disease denotes pleural complications MESH:D010995
55 1522-1543 Disease denotes pleural complications MESH:D010995

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T3 0-8 Sentence denotes Abstract
T4 10-20 Sentence denotes OBJECTIVES
T5 21-180 Sentence denotes Severe acute respiratory syndrome coronavirus 2, a novel coronavirus, affects mainly the pulmonary parenchyma and produces significant morbidity and mortality.
T6 181-298 Sentence denotes During the pandemic, several complications have been shown to be associated with coronavirus disease 2019 (COVID-19).
T7 299-527 Sentence denotes Our goal was to present a series of patients with COVID-19 who underwent chest tube placements due to the development of pleural complications and to make suggestions for the insertion and follow-up management of the chest tube.
T8 529-536 Sentence denotes METHODS
T9 537-680 Sentence denotes We retrospectively collected and analysed data on patients with laboratory-confirmed COVID-19 in our hospital between 11 March and 15 May 2020.
T10 681-808 Sentence denotes Patients from this patient group who developed pleural complications requiring chest tube insertion were included in the study.
T11 810-817 Sentence denotes RESULTS
T12 818-898 Sentence denotes A total of 542 patients who were suspected of having COVID-19 were hospitalized.
T13 899-1062 Sentence denotes The presence of severe acute respiratory syndrome coronavirus 2 was confirmed with laboratory tests in 342 patients between 11 March and 15 May 2020 in our centre.
T14 1063-1116 Sentence denotes A chest tube was used in 13 (3.8%) of these patients.
T15 1117-1229 Sentence denotes A high-efficiency particulate air filter mounted double-bottle technique was used to prevent viral transmission.
T16 1231-1242 Sentence denotes CONCLUSIONS
T17 1243-1365 Sentence denotes In patients with COVID-19, the chest tube can be applied in cases with disease or treatment-related pleural complications.
T18 1366-1451 Sentence denotes Our case series comprised a small group of patients, which is one of its limitations.
T19 1452-1656 Sentence denotes Still, our main goal was to present our experience with patients with pleural complications and describe a new drainage technique to prevent viral transmission during chest tube application and follow-up.